Literature DB >> 18288641

The potential role of ribosomal protein S5 on cell cycle arrest and initiation of murine erythroleukemia cell differentiation.

Christina N Matragkou1, Eleni T Papachristou, Sotirios S Tezias, Asterios S Tsiftsoglou, Theodora Choli-Papadopoulou, Ioannis S Vizirianakis.   

Abstract

Evidence now exists to indicate that some ribosomal proteins besides being structural components of the ribosomal subunits are involved in the regulation of cell differentiation and apoptosis. As we have shown earlier, initiation of erythroid differentiation of murine erythroleukemia (MEL) cells is associated with transcriptional inactivation of genes encoding ribosomal RNAs and ribosomal proteins S5 (RPS5) and L35a. In this study, we extended these observations and investigated whether transfection of MEL cells with RPS5 cDNA affects the onset of initiation of erythroid maturation and their entrance in cell cycle arrest. Stably transfected MEL cloned cells (MEL-C14 and MEL-C56) were established and assessed for their capacity to produce RPS5 RNA transcript and its translated product. The impact of RPS5 cDNA transfection on the RPS5 gene expression patterns and the accumulation of RPS5 protein in inducible transfected MEL cells were correlated with their ability to: (a) initiate differentiation, (b) enter cell cycle arrest at G(1)/G(0) phase, and (c) modulate the level of cyclin-dependent kinases CDK2, CDK4, and CDK6. The data presented indicate that deregulation of RPS5 gene expression (constitutive expression) affects RPS5 protein level and delays both the onset of initiation of erythroid maturation and entrance in cell cycle arrest in inducer-treated MEL cells. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288641     DOI: 10.1002/jcb.21722

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

Review 1.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

2.  RNA interference-mediated knockdown of SIRT1 and/or SIRT2 in melanoma: Identification of downstream targets by large-scale proteomics analysis.

Authors:  Melissa J Wilking-Busch; Mary A Ndiaye; Xiaoqi Liu; Nihal Ahmad
Journal:  J Proteomics       Date:  2017-09-05       Impact factor: 4.044

3.  The histone methyltransferase inhibitor A-366 enhances hemoglobin expression in erythroleukemia cells upon co-exposure with chemical inducers in culture.

Authors:  Christos I Papagiannopoulos; Nikoleta F Theodoroula; Konstantinos A Kyritsis; Melpomeni G Akrivou; Maria Kosmidou; Konstantina Tsouderou; Nikolaos Grigoriadis; Ioannis S Vizirianakis
Journal:  J Biol Res (Thessalon)       Date:  2021-01-06       Impact factor: 1.889

4.  Analysis of Gene Co-Expression Network to Identify the Role of CD8 + T Cell Infiltration-Related Biomarkers in High-Grade Glioma.

Authors:  Peng Feng; Yuchen Li; Zhijie Tian; Yuan Qian; Xingyu Miao; Yuelin Zhang
Journal:  Int J Gen Med       Date:  2022-02-22

5.  Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies.

Authors:  Christos I Papagiannopoulos; Konstantinos A Kyritsis; Konstantina Psatha; Dimitra Mavridou; Fani Chatzopoulou; Georgia Orfanoudaki; Michalis Aivaliotis; Ioannis S Vizirianakis
Journal:  Front Mol Biosci       Date:  2022-02-03

6.  Hypoxic transcription gene profiles under the modulation of nitric oxide in nuclear run on-microarray and proteomics.

Authors:  Emeka I Igwe; Silke Essler; Natalie Al-Furoukh; Nathalie Dehne; Bernhard Brüne
Journal:  BMC Genomics       Date:  2009-09-02       Impact factor: 3.969

7.  Roles of EvpP in Edwardsiella piscicida-Macrophage Interactions.

Authors:  Lei Qin; Xingqiang Wang; Yingli Gao; Keran Bi; Weixia Wang
Journal:  Front Cell Infect Microbiol       Date:  2020-02-14       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.